Insider Trading History of Orbimed Israel Biofund Gp Limited Partnership


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Orbimed Israel Biofund Gp Limited Partnership since year 2005. The trader's CIK number is 1569821. At the time of the last reporting, Orbimed Israel Biofund Gp Limited Partnership was the Officer of Novus Therapeutics, Inc. . (stock ticker symbol NVUS). See this page for all insider trading activities at Novus Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Orbimed Israel Biofund Gp Limited Partnership since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-05-02 NVUS Novus Therapeutics, Inc. Buy 646,204 3.10 2,003,232

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Orbimed Israel Biofund Gp Limited Partnership (Officer of Novus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.